Development and validation of bile acid profile-based scoring system for identification of biliary atresia: a prospective study

BMC Pediatr. 2020 May 27;20(1):255. doi: 10.1186/s12887-020-02169-8.

Abstract

Background: Early distinguishing biliary atresia from other causes of infantile cholestasis remains a major challenge. We aimed to develop and validate a scoring system based on bile acid for identification of biliary atresia.

Methods: In a prospective study, a total of 141 infants with cholestasis were enrolled in two sets (derivation cohort, n = 66; validation cohort, n = 75) from 2014 to 2018. Variables with significant difference between biliary atresia and non-biliary atresia infants were selected in the derivation cohort. Then, a scoring system including those variables was designed and validated.

Results: Among 66 patients in the derivation cohort, 34 (51.5%) had biliary atresia. A scoring system was proposed with the following variables: glycochenodeoxycholic acid/chenodeoxycholic acid, clay stool, and gamma-glutamyl transferase. The total score ranged from 0 to 41, and a cutoff value of 15 identified biliary atresia with an area under receiver operating characteristic curve of 0.87 (95% confidence interval, 0.77-0.94), sensitivity of 85.3%, and specificity of 81.3% in the derivation cohort; these values were also confirmed in a validation cohort with a sensitivity of 90.0% and specificity of 80.0%.

Conclusions: The proposed simple scoring system had good diagnostic accuracy for estimating the risk of biliary atresia in infants with cholestasis.

Keywords: Bile acid; Biliary atresia; Infantile cholestasis; Scoring system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bile Acids and Salts
  • Biliary Atresia* / diagnosis
  • Cholestasis* / diagnosis
  • Cholestasis* / etiology
  • Humans
  • Infant
  • Prospective Studies
  • gamma-Glutamyltransferase

Substances

  • Bile Acids and Salts
  • gamma-Glutamyltransferase